
    
      Primary objective of the studies:

        -  Study 1: To evaluate the efficacy of IAC in term of local control of the disease in
           patients eligible for IAC (randomized phase II study);

        -  Study 2: To assess the visual function, based on World Health Organization (WHO)
           criteria, in patients eligible for other conservative treatments (IV chemotherapy in
           association with local ophthalmologic treatments; this is a minimally invasive
           interventional study).
    
  